|
CA2982162A1
|
|
Self-emulsifying formulations of dim-related indoles
|
|
BRPI0717753A2
|
|
METHOD OF TREATING OR REDUCING THE RISK OF A DISEASE CAUSED BY PROTOZOAN AND, COMPOSITION.
|
|
CA2603235A1
|
|
Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
|
|
WO2006083458A2
|
|
Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
|
|
WO2006047716A2
|
|
Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease
|
|
BRPI0510717A
|
|
Use of 3,3 'diindolylmethane (DIM) or 2- (indol-3-ylmethyl) -3,3'-diindolylmethane (LTR)
|
|
EP1601367A2
|
|
The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions
|
|
US7384971B2
|
|
Phytochemicals for the treatment of cervical dysplasia
|
|
US7348352B2
|
|
Diindolylmethane for the treatment of HPV infection
|
|
US6416793B1
|
|
Formulations and use of controlled-release indole alkaloids
|
|
US6534085B1
|
|
Phytochemicals for promoting weight loss
|
|
US6689387B1
|
|
Phytochemicals for treatment of mastalgia and endometriosis
|
|
US6086915A
|
|
Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
|
|
US6093706A
|
|
Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
|
